Bjorn Dalhus

Title: Biography of Inventor Bjorn Dalhus

Introduction

Bjorn Dalhus, located in Hagen, Norway, is an innovative inventor recognized for his contributions to biopharmaceuticals. With one notable patent under his name, he has made significant strides in the field of albumin variants, demonstrating a commitment to advancing medical technology.

Latest Patents

Dalhus is credited with a patent concerning "Albumin variants." This patent encompasses variants of a parent albumin that possess altered plasma half-lives compared to the parent albumin. It includes fusion polypeptides and conjugates featuring these variant albumins, as well as various embodiments that involve polypeptides with specific alterations at designated positions within the amino acid sequence.

Career Highlights

Currently, Bjorn Dalhus is affiliated with Novozymes Biopharma DIC A/S, where he utilizes his expertise in biochemistry and molecular biology to further his innovative research. His work primarily focuses on the development of modified albumin proteins that can enhance therapeutic applications.

Collaborations

In his professional journey, Dalhus has collaborated with notable colleagues such as Jan Terje Andersen and Inger Sandlie. Together, they contribute to ongoing research aiming to refine and optimize therapeutic proteins for better patient outcomes.

Conclusion

Bjorn Dalhus stands as a prominent figure in the realm of biopharmaceutical innovations. His patent on albumin variants reflects a thought leader's vision that aims to improve existing medical treatments. As he continues to collaborate and innovate within Novozymes Biopharma DIC A/S, the impact of his work is sure to resonate within the medical community.